Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-007032

Director sold 30,000 shares at an average $16.66 ($499,923)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Director 2023-02-01 Sale −25,000 $16.75 $418,675 1,180,763 D
Walker Neal Director 2023-02-02 Sale −1,079 $14.57 $15,718 1,179,684 D
Walker Neal Director 2023-02-02 Sale −600 $15.55 $9,332 1,179,084 D
Walker Neal Director 2023-02-02 Sale −3,121 $16.88 $52,691 1,175,963 D
Walker Neal Director 2023-02-02 Sale −200 $17.54 $3,507 1,175,763 D
Open-market sales · 30,000 sh · avg $16.66 · $499,923
Loading xslF345X03/doc4.xml…